ArticleJournal of neurology2025

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).

Tobias Monschein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.